Why the study?
Does T1 mapping CMR at 3T accurately quantify the area-at-risk and assess myocardial salvage compared to T2 mapping in reperfused STEMI patients?
Does T1 mapping CMR at 3T accurately quantify the area-at-risk and assess myocardial salvage compared to T2 mapping in reperfused STEMI patients?
T1 mapping at 3T performs as well as T2 mapping for quantifying the area-at-risk and myocardial salvage in reperfused STEMI patients, offering a viable alternative CMR measure.
No takes yet. Share an insight, caveat, or question.
T1 mapping may quantify AAR comparably to T2 in STEMI; supports further validation but should not yet change practice.
Bulluck et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: